Compliance Rate
Compliance Rate
0%
Compliant submissions
0
Incompliant submissions
0
Total trials
0
My Organizations' Clinical Trials
Showing 25 of 50 entries
View as:
Phase: N/A
Priority: Normal
Start: 08/24/24
End: 09/01/25
Due: 09/01/26
Phase: N/A
Priority: Normal
Start: 05/15/21
End: 05/15/23
Due: 05/15/24
Efficacy of Mefloquine as Prophylaxis Against COVID-19: A Placebo-control, Randomized Clinical Trial
Phase: N/A
Priority: Normal
Start: 03/28/21
End: 06/30/22
Due: 06/30/23
Phase: N/A
Priority: Normal
Start: 07/15/21
End: 01/20/23
Due: 01/20/24
Phase: N/A
Priority: Normal
Start: 08/01/24
End: 12/31/25
Due: 12/31/26
Phase: N/A
Priority: Normal
Start: 04/01/22
End: 11/01/22
Due: 11/01/23
Phase: N/A
Priority: Normal
Start: 05/28/24
End: 04/01/25
Due: 04/01/26
Phase: N/A
Priority: Normal
Start: 01/01/24
End: 08/30/24
Due: 08/30/25
Phase: N/A
Priority: Normal
Start: 04/01/24
End: 01/01/25
Due: 01/01/26
Phase: N/A
Priority: Normal
Start: 09/01/21
End: 02/01/24
Due: 02/01/25
Phase: N/A
Priority: Normal
Start: 03/10/24
End: 09/25/24
Due: 09/25/25
Phase: N/A
Priority: Normal
Start: 10/13/20
End: 10/30/23
Due: 10/30/24
Phase: N/A
Priority: Normal
Start: 03/01/17
End: 03/29/20
Due: 03/29/21
Phase: N/A
Priority: Normal
Start: 12/26/18
End: 12/26/20
Due: 12/26/21
Phase: N/A
Priority: Normal
Start: 03/14/24
End: 04/30/25
Due: 04/30/26
Phase: N/A
Priority: Normal
Start: 03/01/21
End: 05/01/25
Due: 05/01/26
Phase: N/A
Priority: Normal
Start: 03/01/20
End: 06/01/22
Due: 06/01/23
Phase: N/A
Priority: Normal
Start: 07/13/23
End: 08/31/24
Due: 08/31/25
Phase: N/A
Priority: Normal
Start: 07/20/21
End: 05/20/23
Due: 05/20/24
Phase: N/A
Priority: Normal
Start: 05/01/22
End: 07/01/23
Due: 07/01/24
Phase: N/A
Priority: Normal
Start: 07/01/24
End: 09/01/26
Due: 09/01/27
Phase: N/A
Priority: Normal
Start: 10/01/20
End: 06/01/22
Due: 06/01/23
Phase: N/A
Priority: Normal
Start: 12/20/23
End: 06/30/25
Due: 06/30/26
Phase: N/A
Priority: Normal
Start: 03/07/24
End: 01/31/25
Due: 01/31/26
Phase: N/A
Priority: Normal
Start: 01/15/24
End: 11/15/24
Due: 11/15/25